$AMRI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALBANY MOLECULAR RESEARCH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALBANY MOLECULAR RESEARCH INC. Get notifications about new insider transactions in ALBANY MOLECULAR RESEARCH INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | FINE MARGALIT | Executive Vice Pres ... | Option Exercise | D | 18.41 | 21,725 | 399,957 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | FINE MARGALIT | Executive Vice Pres ... | Sell | D | 21.75 | 23,543 | 512,060 | 0 | 23.5 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | FINE MARGALIT | Executive Vice Pres ... | Grant | A | 0.00 | 2,318 | 0 | 23,543 | 21.2 K to 23.5 K (+10.92 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | FINE MARGALIT | Executive Vice Pres ... | Grant | A | 0.00 | 10,000 | 0 | 21,225 | 11.2 K to 21.2 K (+89.09 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP, Treasurer & CF ... | Option Exercise | D | 18.41 | 46,791 | 861,422 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP, Treasurer & CF ... | Option Exercise | D | 15.77 | 31,609 | 498,474 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP, Treasurer & CF ... | Option Exercise | D | 17.05 | 19,078 | 325,280 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP, Treasurer & CF ... | Option Exercise | D | 16.70 | 75,000 | 1,252,500 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP, Treasurer & CF ... | Sell | D | 21.75 | 63,568 | 1,382,604 | 0 | 63.6 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP, Treasurer & CF ... | Grant | A | 0.00 | 4,993 | 0 | 63,568 | 58.6 K to 63.6 K (+8.52 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 18.41 | 29,412 | 541,475 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 15.77 | 22,889 | 360,960 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 17.05 | 16,280 | 277,574 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 10.43 | 20,000 | 208,600 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 5.99 | 3,750 | 22,463 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 5.99 | 3,750 | 22,463 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 5.99 | 7,500 | 44,925 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 2.93 | 3,750 | 10,988 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | D | 21.75 | 43,655 | 949,496 | 0 | 43.7 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Grant | A | 0.00 | 3,138 | 0 | 43,655 | 40.5 K to 43.7 K (+7.74 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 18.41 | 9,358 | 172,281 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 15.77 | 6,540 | 103,136 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 17.05 | 6,881 | 117,321 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 10.43 | 7,201 | 75,106 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 5.99 | 12,367 | 74,078 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 2.59 | 10,000 | 25,900 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 5.28 | 10,000 | 52,800 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 6.15 | 10,000 | 61,500 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 8.81 | 10,000 | 88,100 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 9.19 | 5,000 | 45,950 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 13.54 | 5,000 | 67,700 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Sell | D | 21.75 | 58,275 | 1,267,481 | 0 | 58.3 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | NAPOLITANO FERNANDO | Director | Option Exercise | D | 18.41 | 9,358 | 172,281 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | NAPOLITANO FERNANDO | Director | Sell | D | 21.75 | 3,802 | 82,694 | 0 | 3.8 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Deming David H | Director | Option Exercise | D | 18.41 | 9,358 | 172,281 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Deming David H | Director | Sell | D | 21.75 | 6,838 | 148,727 | 0 | 6.8 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Gutierrez Fuentes Luis Gerardo | Director | Option Exercise | D | 18.41 | 9,358 | 172,281 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Gutierrez Fuentes Luis Gerardo | Director | Option Exercise | D | 15.77 | 6,540 | 103,136 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Gutierrez Fuentes Luis Gerardo | Director | Sell | D | 21.75 | 2,200,000 | 47,850,000 | 0 | 2.2 M to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Gutierrez Fuentes Luis Gerardo | Director | Sell | D | 21.75 | 6,656 | 144,768 | 0 | 6.7 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HAGEN KENNETH PAUL | Director | Option Exercise | D | 18.41 | 9,358 | 172,281 | 9,358 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HAGEN KENNETH PAUL | Director | Sell | D | 21.75 | 6,838 | 148,727 | 0 | 6.8 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | MADDALUNA ANTHONY J | Director | Option Exercise | D | 18.41 | 9,358 | 172,281 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | MADDALUNA ANTHONY J | Director | Option Exercise | D | 15.77 | 6,540 | 103,136 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | MADDALUNA ANTHONY J | Director | Sell | D | 21.75 | 11,210 | 243,818 | 0 | 11.2 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Option Exercise | D | 18.41 | 9,358 | 172,281 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Option Exercise | D | 15.77 | 6,540 | 103,136 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Option Exercise | D | 17.05 | 6,881 | 117,321 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Option Exercise | D | 10.43 | 7,201 | 75,106 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Option Exercise | D | 5.99 | 20,000 | 119,800 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Option Exercise | D | 5.99 | 20,000 | 119,800 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Option Exercise | D | 5.99 | 20,000 | 119,800 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Option Exercise | D | 2.93 | 20,000 | 58,600 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Option Exercise | D | 2.93 | 20,000 | 58,600 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Sell | D | 21.75 | 2,393,339 | 52,055,123 | 0 | 2.4 M to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Gift | G | 0.00 | 46,200 | 0 | 2,393,339 | 2.4 M to 2.4 M (-1.89 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Gift | G | 0.00 | 2,000 | 0 | 2,439,539 | 2.4 M to 2.4 M (-0.08 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Gift | G | 0.00 | 2,400 | 0 | 2,441,539 | 2.4 M to 2.4 M (-0.10 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Gift | G | 0.00 | 11,100 | 0 | 2,443,939 | 2.5 M to 2.4 M (-0.45 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Gift | G | 0.00 | 23,050 | 0 | 2,455,039 | 2.5 M to 2.5 M (-0.93 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | CONWAY CHRISTOPHER M. | SVP, Discovery and ... | Option Exercise | D | 18.41 | 21,056 | 387,641 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | CONWAY CHRISTOPHER M. | SVP, Discovery and ... | Option Exercise | D | 15.77 | 21,799 | 343,770 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | CONWAY CHRISTOPHER M. | SVP, Discovery and ... | Option Exercise | D | 17.05 | 12,591 | 214,677 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | CONWAY CHRISTOPHER M. | SVP, Discovery and ... | Option Exercise | D | 10.43 | 20,833 | 217,288 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | CONWAY CHRISTOPHER M. | SVP, Discovery and ... | Option Exercise | D | 2.29 | 33,670 | 77,104 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | CONWAY CHRISTOPHER M. | SVP, Discovery and ... | Sell | D | 21.75 | 47,477 | 1,032,625 | 0 | 47.5 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | CONWAY CHRISTOPHER M. | SVP, Discovery and ... | Grant | A | 0.00 | 2,247 | 0 | 47,477 | 45.2 K to 47.5 K (+4.97 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Option Exercise | D | 18.41 | 56,818 | 1,046,019 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Option Exercise | D | 15.77 | 42,145 | 664,627 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Option Exercise | D | 17.05 | 19,078 | 325,280 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Option Exercise | D | 10.43 | 29,167 | 304,212 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Option Exercise | D | 10.25 | 100,000 | 1,025,000 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Sell | D | 21.75 | 129,150 | 2,809,013 | 0 | 129.2 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Grant | A | 0.00 | 6,064 | 0 | 129,150 | 123.1 K to 129.2 K (+4.93 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | BOYER MILTON | SVP, Drug Product M ... | Option Exercise | D | 18.41 | 29,980 | 551,932 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | BOYER MILTON | SVP, Drug Product M ... | Option Exercise | D | 15.77 | 16,349 | 257,824 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | BOYER MILTON | SVP, Drug Product M ... | Option Exercise | D | 17.05 | 12,591 | 214,677 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | BOYER MILTON | SVP, Drug Product M ... | Sell | D | 21.75 | 42,109 | 915,871 | 0 | 42.1 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | BOYER MILTON | SVP, Drug Product M ... | Grant | A | 0.00 | 3,199 | 0 | 42,109 | 38.9 K to 42.1 K (+8.22 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 18.41 | 44,251 | 814,661 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 15.77 | 29,066 | 458,371 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 17.05 | 22,893 | 390,326 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 10.43 | 29,167 | 304,212 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 5.99 | 4,375 | 26,206 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 5.99 | 4,375 | 26,206 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 5.99 | 17,500 | 104,825 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 5.99 | 4,375 | 26,206 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 2.93 | 17,500 | 51,275 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 2.93 | 4,375 | 12,819 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 2.93 | 4,375 | 12,819 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 5.25 | 17,500 | 91,875 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 4.87 | 50,000 | 243,500 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Sell | D | 21.75 | 66,717 | 1,451,095 | 0 | 66.7 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Grant | A | 0.00 | 4,722 | 0 | 66,717 | 62 K to 66.7 K (+7.62 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Gift | G | 0.00 | 9,857 | 0 | 52,138 | 62 K to 52.1 K (-15.90 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Option Exercise | D | 18.41 | 133,690 | 2,461,233 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Option Exercise | D | 15.77 | 54,498 | 859,433 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Sell | D | 21.75 | 483,033 | 10,505,968 | 0 | 483 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Sell | J | 0.00 | 20,383 | 0 | 483,033 | 503.4 K to 483 K (-4.05 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Sell | J | 0.00 | 18,472 | 0 | 503,416 | 521.9 K to 503.4 K (-3.54 %) |
Jul 18 2017 | AMRI | ALBANY MOLECULAR R ... | FINE MARGALIT | Executive Vice Pres ... | Payment of Exercise | F | 21.68 | 1,500 | 32,520 | 11,225 | 12.7 K to 11.2 K (-11.79 %) |
Jul 18 2017 | AMRI | ALBANY MOLECULAR R ... | FINE MARGALIT | Executive Vice Pres ... | Grant | A | 0.00 | 5,000 | 0 | 12,725 | 7.7 K to 12.7 K (+64.72 %) |
Jul 06 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Grant | A | 16.04 | 1,324 | 21,237 | 123,086 | 121.8 K to 123.1 K (+1.09 %) |
Jul 06 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 16.04 | 884 | 14,179 | 521,888 | 521 K to 521.9 K (+0.17 %) |
Jul 06 2017 | AMRI | ALBANY MOLECULAR R ... | BOYER MILTON | SVP, Drug Product M ... | Grant | A | 16.04 | 1,043 | 16,730 | 38,910 | 37.9 K to 38.9 K (+2.75 %) |
Jul 05 2017 | AMRI | ALBANY MOLECULAR R ... | BOYER MILTON | SVP, Drug Product M ... | Payment of Exercise | F | 21.72 | 1,619 | 35,165 | 37,867 | 39.5 K to 37.9 K (-4.10 %) |
May 26 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | M | 14.47 | 5,000 | 72,350 | 0 | |
May 26 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | M | 14.47 | 5,000 | 72,350 | 58,275 | 53.3 K to 58.3 K (+9.39 %) |
May 26 2017 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | M | 14.47 | 5,000 | 72,350 | 0 | |
May 26 2017 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Buy | M | 14.47 | 5,000 | 72,350 | 52,575 | 47.6 K to 52.6 K (+10.51 %) |
Mar 06 2017 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP, Treasurer & CF ... | Payment of Exercise | F | 14.52 | 361 | 5,242 | 58,575 | 58.9 K to 58.6 K (-0.61 %) |
Mar 06 2017 | AMRI | ALBANY MOLECULAR R ... | CONWAY CHRISTOPHER M. | SVP, Discovery and ... | Payment of Exercise | F | 14.52 | 271 | 3,935 | 45,230 | 45.5 K to 45.2 K (-0.60 %) |
Mar 06 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Payment of Exercise | F | 14.52 | 361 | 5,242 | 121,762 | 122.1 K to 121.8 K (-0.30 %) |
Mar 06 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Payment of Exercise | F | 14.52 | 432 | 6,273 | 61,995 | 62.4 K to 62 K (-0.69 %) |
Mar 06 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 14.52 | 350 | 5,082 | 40,517 | 40.9 K to 40.5 K (-0.86 %) |
Feb 21 2017 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP, Treasurer & CF ... | Payment of Exercise | F | 18.71 | 2,097 | 39,235 | 58,936 | 61 K to 58.9 K (-3.44 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | A | 18.41 | 44,251 | 814,661 | 44,251 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Grant | A | 0.00 | 6,747 | 0 | 62,427 | 55.7 K to 62.4 K (+12.12 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Grant | A | 0.00 | 8,990 | 0 | 55,680 | 46.7 K to 55.7 K (+19.25 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 18.41 | 9,358 | 172,281 | 9,358 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Grant | A | 0.00 | 3,802 | 0 | 46,845 | 43 K to 46.8 K (+8.83 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | A | 18.41 | 9,358 | 172,281 | 9,358 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Grant | A | 0.00 | 3,802 | 0 | 47,575 | 43.8 K to 47.6 K (+8.69 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | NAPOLITANO FERNANDO | Director | Option Exercise | A | 18.41 | 9,358 | 172,281 | 9,358 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | NAPOLITANO FERNANDO | Director | Grant | A | 0.00 | 3,802 | 0 | 3,802 | 0 to 3.8 K |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 18.41 | 9,358 | 172,281 | 9,358 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 0.00 | 3,802 | 0 | 53,275 | 49.5 K to 53.3 K (+7.68 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Deming David H | Director | Option Exercise | A | 18.41 | 9,358 | 172,281 | 9,358 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Deming David H | Director | Grant | A | 0.00 | 3,802 | 0 | 6,838 | 3 K to 6.8 K (+125.23 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | HAGEN KENNETH PAUL | Director | Option Exercise | A | 18.41 | 9,358 | 172,281 | 9,358 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | HAGEN KENNETH PAUL | Director | Grant | A | 0.00 | 3,802 | 0 | 6,838 | 3 K to 6.8 K (+125.23 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Option Exercise | A | 18.41 | 9,358 | 172,281 | 9,358 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E | Director | Grant | A | 0.00 | 3,802 | 0 | 2,478,089 | 2.5 M to 2.5 M (+0.15 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | FINE MARGALIT | Executive Vice Pres ... | Option Exercise | A | 18.41 | 21,725 | 399,957 | 21,725 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | FINE MARGALIT | Executive Vice Pres ... | Grant | A | 0.00 | 3,312 | 0 | 7,725 | 4.4 K to 7.7 K (+75.05 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | FINE MARGALIT | Executive Vice Pres ... | Grant | A | 0.00 | 4,413 | 0 | 4,413 | 0 to 4.4 K |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Option Exercise | A | 18.41 | 133,690 | 2,461,233 | 133,690 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 0.00 | 20,383 | 0 | 521,004 | 500.6 K to 521 K (+4.07 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 0.00 | 27,159 | 0 | 500,621 | 473.5 K to 500.6 K (+5.74 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | MADDALUNA ANTHONY J | Director | Option Exercise | A | 18.41 | 9,358 | 172,281 | 9,358 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | MADDALUNA ANTHONY J | Director | Grant | A | 0.00 | 3,802 | 0 | 11,210 | 7.4 K to 11.2 K (+51.32 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | CONWAY CHRISTOPHER M. | SVP, Discovery and ... | Option Exercise | A | 18.41 | 21,056 | 387,641 | 21,056 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | CONWAY CHRISTOPHER M. | SVP, Discovery and ... | Grant | A | 0.00 | 3,210 | 0 | 45,501 | 42.3 K to 45.5 K (+7.59 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | CONWAY CHRISTOPHER M. | SVP, Discovery and ... | Grant | A | 0.00 | 4,278 | 0 | 42,291 | 38 K to 42.3 K (+11.25 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP, Treasurer & CF ... | Option Exercise | A | 18.41 | 46,791 | 861,422 | 46,791 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP, Treasurer & CF ... | Grant | A | 0.00 | 7,134 | 0 | 61,033 | 53.9 K to 61 K (+13.24 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP, Treasurer & CF ... | Grant | A | 0.00 | 9,506 | 0 | 53,899 | 44.4 K to 53.9 K (+21.41 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Option Exercise | A | 18.41 | 56,818 | 1,046,019 | 56,818 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Grant | A | 0.00 | 8,663 | 0 | 122,123 | 113.5 K to 122.1 K (+7.64 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Grant | A | 0.00 | 11,543 | 0 | 113,460 | 101.9 K to 113.5 K (+11.33 %) |